Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance

IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced preliminary unaudited fourth quarter and full year 2023 revenue and established its 2024 financial guidance. Preliminary Fourth Quarter and Full Year 2023 Highlights Preliminary unaudited revenue for the fourth quarter of 2023 is expected to be at least $132.0 million, up a ...